Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Janice N Thai, Faezeh Sodagari, Amy S Colwell, Jonathan M Winograd, Margarita V Revzin, Hagar Mahmoud, Sara Mozayan, Shinn-Huey S Chou, Stamatia V Destounis, Reni S Butler
For women undergoing mastectomy, breast reconstruction can be performed by using implants or autologous tissue flaps. Mastectomy options include skin- and nipple-sparing techniques. Implant-based reconstruction can be performed with saline or silicone implants. Various autologous pedicled or free tissue flap reconstruction methods based on different tissue donor sites are available. The aesthetic outcomes of implant- and flap-based reconstructions can be improved with oncoplastic surgery, including autologous fat graft placement and nipple-areolar complex reconstruction...
May 2024: Radiographics: a Review Publication of the Radiological Society of North America, Inc
#2
JOURNAL ARTICLE
Kaustav Talapatra, Garvit Chitkara, Sridevi Murali-Nanavati, Ajinkya Gupte, Nikhil S Bardeskar, Shruti Behal, Muzammil Shaikh, Pooja Atluri
The practice of boost to the tumor bed after treatment with oncoplastic breast-conserving surgery (BCS) remains variable. Using a survey, the present study evaluated the current practice of tumor bed boost administered in women after oncoplastic BCS. Actively practicing radiation oncologists across India were sent a questionnaire on the practice of adjuvant whole-breast radiotherapy and tumor bed boost after oncoplastic BCS via email and encouraged to participate. Of the 54 radiation oncologists who participated, most (98...
March 2024: Indian Journal of Surgical Oncology
#3
JOURNAL ARTICLE
Goran A Ahmed, Rabiya Aseem, Hisham Osman
BACKGROUND: The latissimus dorsi myocutaneous flap (LDMF) remains a significant tool in the armamentarium of the oncoplastic breast surgeon. Despite declining popularity for reconstruction, owing to the increasing use of implants and free flaps, it still has an important role in certain salvage situations and as a flap to cover large defects. We report our experience with the use of LDMF for immediate coverage of large mastectomy defects when options are limited. METHODS: Retrospective series of prospectively collected patient records...
February 2024: Curēus
#4
REVIEW
Naohiro Ishii
Breast reconstruction using silicone breast implants (SBIs) has been performed for many patients in Japan under the initiative of the Japan Oncoplastic Breast Surgery Society (JOBSS) since SBIs were first covered by insurance in 2013. A change in the lineup of available SBIs owing to the Allergan crisis caused a decrease in the availability of SBIs appropriate to Japanese breast contours. Recently, the number of immediate implant-based breast reconstructions (IBRs) was approximately 4,000 in one year and was slightly decreasing...
December 26, 2023: Gland Surgery
#5
JOURNAL ARTICLE
Adriana C Panayi, Samuel Knoedler, Leonard Knoedler, Christian Tapking, Gabriel Hundeshagen, Yannick F Diehm, Sebastian Fischer, Oliver C Thamm, Ulrich Kneser, Valentin Haug
Oncoplastic breast surgery (OBS) arose to decrease the deformity following breast conserving surgery (BCS) for breast cancer. In this meta-analysis (MA), we pool Breast-Q™ questionnaire data to compare quality of life (QOL) in breast cancer patients who received BCS alone or in combination with Level I or II oncoplastic breast surgery (BCS+OBS). All relevant databases were searched following the PRISMA and QUOROM guidelines. All prospective or retrospective studies with a BCS or BCS+OBS cohort that reported QOL as assessed with the Breast-Q™ questionnaire were eligible...
January 9, 2024: Aesthetic Surgery Journal
#6
REVIEW
Boran Tekdogan, Jérôme Martineau, Matteo Scampa, Daniel F Kalbermatten, Carlo M Oranges
BACKGROUND: Breast-conserving surgery is the standard of care for early-stage breast cancer but can often result in unsatisfactory cosmetic outcomes. Oncoplastic surgery aims to address these issues by combining local excision with plastic surgery techniques to improve oncologic and esthetic outcomes. By incorporating breast reduction techniques into cancer surgery, wider margins of excision can be achieved, leading to enhanced oncological safety and reduced recurrence rates without causing significant asymmetry...
December 5, 2023: Journal of Plastic, Reconstructive & Aesthetic Surgery: JPRAS
#7
JOURNAL ARTICLE
Carole Mathelin, Susie Brousse, Martin Schmitt, Nicolas Taris, Catherine Uzan, Sébastien Molière, Charlotte Vaysse
OBJECTIVES: Breast surgery is the cornerstone of breast cancer treatment. Its indications and procedures are constantly evolving. To update best practices, four questions were submitted to the Senology Commission (SC) of the Collège National des Gynécologues et Obstétriciens Français (CNGOF), covering the indications and modalities of tumor surgery 1) initially, 2) following neoadjuvant systemic treatment, 3) in case of local recurrence, and 4) the quality and safety of care indicators applicable to this surgery...
December 18, 2023: Gynecologie, Obstetrique, Fertilite & Senologie
#8
JOURNAL ARTICLE
Raghavan Vidya, Muskaan Khosla, Kim Baek, R Vinayagam, Dinesh Thekkinkattil, Siobhan Laws, Stergios Douvetzemis, Tapan Sircar, Amulya Mullapudi, John Murphy
BACKGROUND: Negative pressure wound therapy (NPWT) has emerged as an adjunct to reduce wound complication rates in many surgical domains. This study investigated the prophylactic use of PICO NPWT in high-risk patients undergoing oncoplastic and reconstructive breast surgery. METHODS: This was a prospective multicenter national audit. The findings were compared against Association of Breast Surgery/British Association of Plastic, Reconstructive and Aesthetic Surgeons (ABS/BAPRAS) Oncoplastic Guidelines for best practice...
December 2023: Plastic and Reconstructive Surgery. Global Open
#9
JOURNAL ARTICLE
Chaitanyanand B Koppiker, Devaki A Kelkar, Madhura Kulkarni, Shweta Kadu, Mugdha Pai, Upendra Dhar, Chetan Deshmukh, Beenu Varghese, Vaishali Zamre, Nutan Jumle, Nutan Gangurde, Anjali Joshi, Rohini Unde, Rituja Banale, Namrata Namewar, Pooja Vaid, Laleh Busheri, George Thomas, Smeeta Nare, Jerome Pereira, Sunil Badve
INTRODUCTION: The essential goal of neoadjuvant chemotherapy (NACT) is to downstage the primary tumor making it amenable for breast conservation surgery (BCS). However, since the safety of this surgery is paramount, post-NACT breast conservation rates remain low. As per the recommendation of the 2018 Early Breast Cancer Trialists' Collaborative Group (EBCTCG) overview of long-term post-NACT follow-up, we have devised a protocol for imaging, localization, rad-path analysis, and documentation of radiotherapy techniques to ensure the safety of post-NACT breast conservation...
2023: Frontiers in Oncology
#10
JOURNAL ARTICLE
Derek Muradali, Glenn G Fletcher, Erin Cordeiro, Samantha Fienberg, Ralph George, Supriya Kulkarni, Jean M Seely, Rola Shaheen, Andrea Eisen
BACKGROUND: The use of preoperative breast magnetic resonance imaging (MRI) after the diagnosis of breast cancer by mammography and/or ultrasound is inconsistent. METHODS: After conducting a systematic review and meta-analysis comparing preoperative breast MRI versus no MRI, we reconvened to prepare a clinical practice guideline on this topic. RESULTS: Based on the evidence that MRI improved recurrence, decreased the rates of reoperations (re-excisions or conversion mastectomy), and increased detection of synchronous contralateral breast cancer, we recommend that preoperative breast MRI should be considered on a case-by-case basis in patients diagnosed with breast cancer for whom additional information about disease extent could influence treatment...
June 30, 2023: Current Oncology
#11
REVIEW
Ameer Aldarragi, Nima Farah, Christian M Warner, Ali M Ghasemi, Oghenetega T Ekakitie, Yamen Jabr, Shafiq Rahman
Although prophylactic antibiotic use following autologous breast reconstruction post-mastectomy is a common practice, there is no consensus in the literature regarding its duration. Antibiotic stewardship is important to minimise multi-resistant organisms as well as mitigate the associated side effects. Currently, there are no published guidelines regarding the duration of prophylactic antibiotics in autologous breast reconstruction surgery following mastectomy. The authors searched the online literature regarding the administration of antibiotics for autologous breast reconstruction surgery post-mastectomy...
June 2023: Curēus
#12
JOURNAL ARTICLE
Zaid Al-Ishaq, Hamed Hajiesmaeili, Ehsanur Rahman, Muskaan Khosla, Tapan Sircar
Background The rate of upgrading ductal carcinoma in situ (DCIS) to invasive cancer varies widely in the literature with no consensus regarding sentinel lymph node biopsy (SLNB) for DCIS; however, some guidelines do recommend it in the event of a mastectomy. The primary aim of this study was to determine the upgrade rate of DCIS to invasive carcinoma (IC) in patients undergoing mastectomy for DCIS and identify the clinicopathological predicting factors for the upgrade. The secondary aim was to determine the SLNB positivity rate...
March 2023: Curēus
#13
REVIEW
Hikmat Abdel-Razeq, Fawzi Abu Rous, Fawzi Abuhijla, Nayef Abdel-Razeq, Sarah Edaily
Breast cancer is the most common cancer diagnosed among women worldwide and more than half are diagnosed above the age of 60 years. Life expectancy is increasing and the number of breast cancer cases diagnosed among older women are expected to increase. Undertreatment, mostly due to unjustifiable fears of advanced-age and associated comorbidities, is commonly practiced in this group of patients who are under-represented in clinical trials and their management is not properly addressed in clinical practice guidelines...
2022: Clinical Interventions in Aging
#14
JOURNAL ARTICLE
Maggie Banys-Paluchowski, Marc Thill, Thorsten Kühn, Nina Ditsch, Jörg Heil, Achim Wöckel, Eva Fallenberg, Michael Friedrich, Sherko Kümmel, Volkmar Müller, Wolfgang Janni, Ute-Susann Albert, Ingo Bauerfeind, Jens-Uwe Blohmer, Wilfried Budach, Peter Dall, Peter Fasching, Tanja Fehm, Oleg Gluz, Nadia Harbeck, Jens Huober, Christian Jackisch, Cornelia Kolberg-Liedtke, Hans H Kreipe, David Krug, Sibylle Loibl, Diana Lüftner, Michael Patrick Lux, Nicolai Maass, Christoph Mundhenke, Ulrike Nitz, Tjoung Won Park-Simon, Toralf Reimer, Kerstin Rhiem, Achim Rody, Marcus Schmidt, Andreas Schneeweiss, Florian Schütz, H Peter Sinn, Christine Solbach, Erich-Franz Solomayer, Elmar Stickeler, Christoph Thomssen, Michael Untch, Isabell Witzel, Bernd Gerber
The recommendations of the AGO Breast Committee on the surgical therapy of breast cancer were last updated in March 2022 (www.ago-online.de). Since surgical therapy is one of several partial steps in the treatment of breast cancer, extensive diagnostic and oncological expertise of a breast surgeon and good interdisciplinary cooperation with diagnostic radiologists is of great importance. The most important changes concern localization techniques, resection margins, axillary management in the neoadjuvant setting and the evaluation of the meshes in reconstructive surgery...
October 2022: Geburtshilfe und Frauenheilkunde
#15
JOURNAL ARTICLE
Paige Teller, Toan T Nguyen, Jennifer Tseng, Lisa Allen, Cindy B Matsen, Emily Bellavance, David Kaufman, Tina Hieken, Steven Nagel, Caitlin Patten, Laura Pomerenke, Sarah E Tevis, Terry Sarantou
The adoption of innovation is essential to the evolution of patient care. Breast surgical oncology advances through incorporating new techniques, devices, and procedures. Historical changes in practice standards from radical to modified radical mastectomy or axillary node dissection to sentinel node biopsy reduced morbidity without sacrifice in oncologic outcome. Contemporary oncoplastic techniques afford broader consideration for breast conservation and the potential for improved cosmetic outcomes. At present, many breast surgeons face the decision of which wireless device to use for localization of nonpalpable lesions...
October 2022: Annals of Surgical Oncology
#16
JOURNAL ARTICLE
Arwa Ashoor, Germana Lissidini, Uttaran Datta, Lorenzo Bertoldi, Paolo Veronesi, Melissa Ley-Hui Tan
BACKGROUND: Chyle leak after axillary surgery is a rare complication that lacks consensus and management guidelines. This study aimed to present the experiences of two centers in chyle leak management after axillary node clearance for breast cancer. Furthermore the authors provide a review of its pathophysiology and clinical diagnostic methods. They compare approaches for management of the axilla with those for other locations. METHODS: A multicentre case series descriptive analysis of chyle leak after breast cancer axillary node clearance between 1 January 2013 and 31 May 2020 was performed...
July 18, 2022: Annals of Surgical Oncology
#17
Georgios-Ioannis Verras, Francesk Mulita, Levan Tchabashvili, Ioanna-Maria Grypari, Sofia Sourouni, Evangelia Panagodimou, Maria-Ioanna Argentou
Invasive micropapillary carcinoma (IMPC) is a rare, distinct histological subtype of breast carcinoma. While micropapillary histological architecture is found in up to 2-8% of all breast cancers, pure micropapillary carcinoma is infrequent and comprises 0.9-2% of breast carcinomas. Invasive micropapillary carcinoma is emerging as an oncological and surgical challenge due to a plethora of characteristics that constitute this histological pattern - interestingly, both elusive and aggressive. We present the case of a woman presenting with IMPC, who was primarily treated with tumour and lymph node marking, followed by primary systemic therapy (PST), and consequent oncoplastic surgery with sentinel lymph node biopsy...
March 2022: Menopause Review
#18
REVIEW
Arnaud Beddok, Youlia Kirova, Fatima Laki, Fabien Reyal, Anne Vincent Salomon, Vincent Servois, Alain Fourquet
Several randomized controlled trials have demonstrated the benefit of a boost to the tumor bed (TB) to reduce the risk of ipsilateral breast tumor recurrence. Recent technological progress has facilitated improved conformation of isodoses around the target volume. The accuracy and reproducibility of TB delineation have become even more essential. The purpose of this study is to review the extant knowledge on the boost delineation in breast cancer, focusing on interobserver variability (IOV) and the influence of various factors, such as the presence of clips or different imaging modalities to improve IOV...
May 2022: Radiotherapy and Oncology
#19
REVIEW
Guldeniz Karadeniz Cakmak
Background: Oncoplastic breast conserving surgery (OBCS), which is the current procedure of choice for eligible BC patients, describes a philosophy that prioritizes oncologic and cosmetic outcomes. However, knowledge gaps regarding training, acceptance, and practice preclude standardization and make it difficult to design algorithmic guidelines to optimize individualized management in the era of precision medicine. Summary: The harmony between patient expectations and oncologic goals creates the state of the art of OBCS...
December 2021: Breast Care
#20
JOURNAL ARTICLE
C L Rutherford, S Barker, L Romics
INTRODUCTION: Oncoplastic breast conserving surgery allows higher volume excision to achieve oncological safety with minimal aesthetic compromise. The primary outcome of this study was to assess the oncological safety in the setting of volume replacement oncoplastic breast conserving surgery. The secondary objective was to assess cosmetic outcome. METHODS: A systematic literature review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines to explore the oncological safety of oncoplastic breast conserving surgery, with particular focus on volume replacement...
January 2022: Annals of the Royal College of Surgeons of England
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
